| Literature DB >> 9785472 |
Abstract
Interleukin 1 (IL1) is a primary regulator of inflammatory and immune responses. Via its type I receptor it activates specific protein kinases, including the NF kappa B inducing kinase (NIK) and three distinct mitogen-activated protein (MAP) kinase cascades. These modulate a number of transcription factors including NF kappa B, AP1 and CREB each of which regulate a plethora of immediate early genes central to the inflammatory response. Phase I clinical trials of the soluble type I receptor and IRAP indicate that these have potential anti-inflammatory effects.Entities:
Mesh:
Substances:
Year: 1998 PMID: 9785472 DOI: 10.1016/s1357-2725(98)00081-8
Source DB: PubMed Journal: Int J Biochem Cell Biol ISSN: 1357-2725 Impact factor: 5.085